The end-users of the ventricular assist device industry mainly include patients with end-stage heart failure,as it is the only diagnostic and therapeutic approach for reversing end-stage heart failure other than heart transplantationand has a huge potential demand.Ventricular assist devices have two different ways of entering the body: implantable and interventional. Their core component (the blood pump) has undergone multiple technological iterations. Currently, commercial implantable ventricular assist devices can be classified into sliding bearing ventricular assist devices, magnetically levitated ventricular assist devices, and fully magnetically levitated ventricular assist devices based on their blood pump technology path. With factors such as accelerating population aging and the increasing number of chronic disease patients year by year, the number of heart failure patients in China will continue to grow, creating a huge market space for ventricular assist devices. Frost & Sullivan (Frost & Sullivan) hereby releases an independent research report titled 'Market Research Report on Ventricular Assist Devices’
The attachment is an excerpt from the reportIf you have further research needs on the ventricular assist device market, please contact us at any time:
Frost & Sullivan Mr.Mao
Tel:(+86)159 2139 6033
E-mail: fred.mao@frostchina.com
